Clayton Financial Group’s DexCom DXCM Stock Holding History

Clayton Financial Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25	Closed	-$1.57K	–	218
2026 Q1	$1.57K	Hold	25	–	–	﹤0.01%	505
2025 Q4	$1.66K	Buy	+25	New	+$1.62K	﹤0.01%	490

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clayton Financial Group's DXCM Position: Q2 2026 in Review

Clayton Financial Group sold out of DexCom (DXCM) in Q2 2026, closing a stake of 25 shares — an estimated $1.57K sold.

Clayton Financial Group first reported a position in DXCM in Q4 2025 and held it in 2 quarters. The position peaked at $1.66K in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Clayton Financial Group reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
Clayton Financial Group sold 25 DexCom shares in Q2 2026, an estimated $1.57K.
Clayton Financial Group first reported a position in DexCom in Q4 2025 and held it in 2 quarters.
Clayton Financial Group's DexCom position peaked at $1.66K in Q4 2025.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.